Lilly plans to seek FDA approval for Foundayo to treat sleep apnea

Eli Lilly plans to seek FDA approval for Foundayo to treat sleep apnea, potentially giving its weight-loss pill an edge over Novo Nordisk's oral Wegovy.

Detected & updated continuously · Source: Nebula

Story subjects

Eli Lilly & Co.Novo NordiskFood and Drug AdministrationFoundayosleep apnea

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula